Viatris Inc
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-03-31; filed 2024-05-09.
0001792044-24-000017
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsCurrent report: 10-Q
Period ended 2024-06-30; filed 2024-08-08.
0001792044-24-000025
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 7 previous paragraphs and 2 current paragraphs.
1 unchanged; 1 reworded; 0 added; 5 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Removed paragraphs (5)
Previous report
Viatris Inc.
Previous report
Issuer purchases of equity securities
Previous report
(b)The number of shares purchased is based on the purchase date and not the settlement date.
Previous report
(c)Average price per share includes commissions.
Previous report
(d)On February 26, 2024, the Company’s Board of Directors authorized a $1.0 billion increase to the Company’s previously announced $1.0 billion share repurchase program.
Reworded paragraphs (1)
Previous wording
(a)Refer to Part I, Item 2. Management’s Discussion and Analysis of Financial Condition -Results of Operations – Recent Developments of this Form 10-Q for additional information regarding the Company’s authorized share repurchase program. During the three months ended March 31, 2024, the Company repurchased approximately 19.2 million shares of common stock at a cost of approximately $250 million under this program.
Current wording
There were no repurchases of the Company’s common stock during the three months ended June 30, 2024. Refer to Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations– Recent Developments of this Form 10-Q for additional information regarding the Company’s authorized share repurchase program.